Pepijn W A Thomas
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 08, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.Pepijn W A Thomas, Nathan den Broeder, Monique Derikx
|Jun 02, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.Pepijn W A Thomas, Tessa E H Römkens, Rachel L West
|Feb 04, 2021
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.Eline L Giraud, Pepijn W A Thomas, Jette A van Lint
|Dec 10, 2020
Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease.Michiel E de Jong, Erik Taal, Pepijn W A Thomas
|Nov 21, 2020
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.Pepijn W A Thomas, Rachel L West, Maurice G V M Russel
|Feb 12, 2020
A nationwide survey on therapeutic drug monitoring of anti-tumour necrosis factor agents for inflammatory bowel disease.Pepijn W A Thomas, Paul K L Chin, Murray L Barclay
Pageof 1
